You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 5, May 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (76)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Immunologic Disorders
 •Bone Marrow Transplantation
 •Review
 •Alert me on articles by topic

Cutaneous Graft-versus-Host Disease

Sélim Aractingi, MD, PhD; Olivier Chosidow, MD, PhD

Arch Dermatol. 1998;134:602-612.

Graft-versus-host disease (GvHD) includes inflammatory and/or fibrosing manifestations that may arise at various times after transplantation of any organ containing lymphoid cells. For the dermatologist, the importance of GvHD is real and current. Indeed, because it has become easier to perform bone marrow transplantation (BMT), the indications of BMT have become broader, making follow-up of patients receiving grafts a widespread practice. Nonetheless, GvHD remains a frequent complication of BMT and its principal target organ is the skin. Furthermore, recent innovations, such as grafting of umbilical cord blood and the mobilization of peripheral blood progenitor cells, will be the source of new questions concerning the development of GvHD under these conditions. Finally, because of its analogies with other spontaneous idiopathic skin diseases, GvHD constitutes a model that may lead to a better understanding of the pathophysiological features of these diseases. In this review, the cutaneous aspects of GvHD are emphasized.


From the Department of Dermatology, Hôpital Tenon (Dr Aractingi), and the Department of Internal Medicine, Hôpital Pitié-Salpêtrière (Dr Chosidow), Paris, France.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cutaneous lichenoid graft-versus-host disease mimicking lupus erythematosus
Goiriz et al.
Lupus 2008;17:591-595.
ABSTRACT  

CD4+ T Cells Generated De Novo from Donor Hemopoietic Stem Cells Mediate the Evolution from Acute to Chronic Graft-versus-Host Disease
Zhang et al.
J. Immunol. 2007;179:3305-3314.
ABSTRACT | FULL TEXT  

Role of Skin Biopsy to Confirm Suspected Acute Graft-vs-Host Disease: Results of Decision Analysis.
Firoz et al.
Arch Dermatol 2006;142:175-182.
ABSTRACT | FULL TEXT  

My approach to superficial inflammatory dermatoses
Alsaad and Ghazarian
J. Clin. Pathol. 2005;58:1233-1241.
ABSTRACT | FULL TEXT  

New approaches for preventing and treating chronic graft-versus-host disease
Lee
Blood 2005;105:4200-4206.
ABSTRACT | FULL TEXT  

Sclerodermatous Graft-vs-Host Disease: Clinical and Pathological Study of 17 Patients
Penas et al.
Arch Dermatol 2002;138:924-934.
ABSTRACT | FULL TEXT  

Late Appearance of Acute Graft-vs-Host Disease After Suspending or Tapering Immunosuppressive Drugs
Valks et al.
Arch Dermatol 2001;137:61-65.
ABSTRACT | FULL TEXT  

Columnar Epidermal Necrosis: A Unique Manifestation of Transfusion-Associated Cutaneous Graft-vs-Host Disease
Saijo et al.
Arch Dermatol 2000;136:743-746.
ABSTRACT | FULL TEXT  

Human Herpesviruses 6 and 7: New Roles Yet to Be Discovered?
Le Cleach et al.
Arch Dermatol 1998;134:1155-1157.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.